Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy
Main Authors: | Shizhen Zhang, Yi Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420300931 |
Similar Items
-
Structural insights into E1 recognition and the ubiquitin-conjugating activity of the E2 enzyme Cdc34
by: Katelyn M. Williams, et al.
Published: (2019-07-01) -
Nutrient sensing kinases PKA and Sch9 phosphorylate the catalytic domain of the ubiquitin-conjugating enzyme Cdc34.
by: Ross Cocklin, et al.
Published: (2011-01-01) -
The ubiquitin-conjugating enzyme CDC34 is essential for cytokinesis in contrast to putative subunits of a SCF complex in Trypanosoma brucei.
by: Federico Rojas, et al.
Published: (2017-06-01) -
Ubiquitin-Conjugating Enzymes in Cancer
by: Quyen Thu Bui, et al.
Published: (2021-06-01) -
The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy
by: Xiaodi Du, et al.
Published: (2021-03-01)